# The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis

Study · id `cardio:ct-nct03862859` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03862859](<https://clinicaltrials.gov/study/NCT03862859>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03862859

Browse, organ or system: Heart; Brain; Kidneys  
Browse, condition area: Stroke; Heart rhythm problems; Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 718 participants.

## Technical summary

Registry record NCT03862859. Randomized; no masking; primary purpose prevention. Start 2019-10-09 (actual); primary completion 2027-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 718 participants (planned count; ClinicalTrials.gov record NCT03862859, source copy `cardio:ctgov-nct03862859-2026-05-19`, retrieved 2026-10-26)
- Started: 2019-10-09 (actual) (ClinicalTrials.gov record NCT03862859, source copy `cardio:ctgov-nct03862859-2026-05-19`, retrieved 2026-10-26)
- Primary completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT03862859, source copy `cardio:ctgov-nct03862859-2026-05-19`, retrieved 2026-10-26)
- Completion: 2027-01 (anticipated) (ClinicalTrials.gov record NCT03862859, source copy `cardio:ctgov-nct03862859-2026-05-19`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT03862859, source copy `cardio:ctgov-nct03862859-2026-05-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03862859-2026-05-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
- Acronym: DANWARD
- Condition: Atrial Fibrillation and Flutter
- Condition: Stroke
- Condition: Major Bleed
- Condition: End-stage Renal Disease
- Intervention (Drug): Warfarin
- Lead sponsor: Nicholas Carlson
- Lead sponsor class: OTHER
- Collaborator: Danish Heart Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Warfarin (`core:warfarin`)
- Registry lists this organization as a collaborator: Danish Heart Foundation (`cardio:org-danish-heart-foundation`)

## Provenance

Content hash: 28f176a764ff5587c75bfea82e7457ab55d2f9cfaf5aaf83797340397fe39ed6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
